Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P444: High-dose intravenous iron isomaltoside infusion is not associated with an increase in intact fibroblast growth factor 23 (iFGF23) in patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

J. F. Dahlerup*1, S. Lindgren2

1Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark, 2Lund University, University Hospital MAS, Department of Gastroenterology, Malmö, Sweden

P445: Early outcomes for adolescent inflammatory bowel disease patients treated in a transition clinicECCO '16 Amsterdam
Year: 2016
Authors:

I. Avni-Biron1, G. Fraser*1, Y. Rosenbach2, R. Shamir2, A. Assa2, L. Lichtenstein1, O. Ben-Bassat1

1Rabin Medical Centre and University of Tel Aviv, Gastroenterology, Petach Tikva, Israel, 2Schneider Children’s Medical Centre, University of Tel Aviv, Paediatric Gastroenterology, Petach Tikva, Israel

P446: Effects of CYP3A5 genotype on efficacy and safety of tacrolimus in refractory ulcerative colitis: experience from a tertiary referral centreECCO '16 Amsterdam
Year: 2016
Authors:

E. Saito*, T. Kobayashi, M. Nakano, T. Toyonaga, S. Kuronuma, O. Takeuchi, H. Serizawa, N. Watanabe, T. Hibi

Kitasato University Kitasato Institute Hospital, Centre for Advanced IBD Research and Treatment, Tokyo, Japan

P447: Seasonal variations in Vitamin D concentrations in a single-centre inflammatory bowel disease seriesECCO '16 Amsterdam
Year: 2016
Authors:

P. Vernia*, G. Burrelli Scotti, M. T. Afferri, V. Vaiarello

Sapienza - University of Rome, Gastroenterologia A, Rome, Italy

P448: IBD nurse in patients’ health status assessment: data from a pilot study comparing ability of IBD nurse and gastroenterologist in using IBD clinical scoresECCO '16 Amsterdam
Year: 2016
Authors:

F. Mocciaro*1, R. Di Mitri1, G. M. Pecoraro1, D. Scimeca2, G. Russo1, F. Bossa2, V. Costanza1, D. Varvara2, M. A. Profita1, G. Profeta1, G. Martino2

1ARNAS Civico-Di Cristina-Benfratelli Hospital, Gastroenterology and Endoscopy Unit, Palermo, Italy, 2Casa Sollievo della Sofferenza Hospital, IRCCS, Division of Gastroenterology, San Giovanni Rotondo (FG), Italy

P449: Efficacy and safety of switching between originator and biosimilar infliximab in patients with inflammatory bowel disease in practical clinic: results to 6 monthsECCO '16 Amsterdam
Year: 2016
Authors:

L. Díaz Hernández*1, G. E. Rodríguez González1, M. Vela González1, C. A. Tardillo Marín1, C. Y. Rodríguez Díaz1, L. Arranz Hernández1, J. A. Montero Delgado2, M. San Juan Acosta1, F. Pérez Hernández1

1Hospital Universitario Ntra. Sra. Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 2Hospital Universitario Ntra. Sra. Candelaria, Pharmacology, Santa Cruz de Tenerife, Spain

P450: A gender comparison of the association between coping strategies and perceived social support in Crohn’s disease patientsECCO '16 Amsterdam
Year: 2016
Authors:

O. Sarid1, V. Slomin-Nevo1, D. Greenberg2, M. Friger3, D. Schwartz4, H. Vardi2, R. Sergienko3, E. Chernin3, S. Odes*5

1Ben-Gurion University of the Negev, Social Work, Beer Sheva, Israel, 2Ben-Gurion University of the Negev, Health Systems Management, Beer Sheva, Israel, 3Ben-Gurion University of the Negev, Public Health, Beer Sheva, Israel, 4Soroka University Hospital, Gastroenterology, Beer Sheva, Israel, 5Ben-Gurion University of the Negev, Gastroenterology, Beer Sheva, Israel

P451: The efficacy of infliximab in tacrolomus non-responder with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

T. Miyazaki*, N. Hida, T. Sato, M. Kawai, K. Kamikozuru, T. Takagawa, Y. Yokoyama, M. Iimuro, K. Hori, S. Nakamura

Hyogo College of Medicine, Division of Internal Medicine Department of Inflammatory Bowel Disease, Nishinomiya, Japan

P452: Safety and efficacy of infliximab biosimilar (Remsima©) in Crohn’s disease patients in clinical practice: results after 6 months of treatmentECCO '16 Amsterdam
Year: 2016
Authors:

M. F. Guerra Veloz*1, F. Argüelles Arias1, R. Perea Amarillo1, L. Castro Laria1, M. B. Maldonado Pérez1, A. Benítez Roldán1, V. Merino2, G. Ramirez2, A. Vilches Arenas3, A. Caunedo Álvarez1

1Unidad de Gestión Clínica de Aparato Digestivo Hospital Universitario Virgen Macarena, Seville, Spain, 2Unidad de Farmacia Hospital Universitario Virgen Macarena, Seville, Spain, 3Universidad de Sevilla, Medicina preventiva y salud pública, Seville, Spain

P453: Insufficient vaccination and inadequate immunisation rates amongst Korean patients with inflammatory bowel diseasesECCO '16 Amsterdam
Year: 2016
Authors:

H. H. Ryu1, H.-S. Lee2, B. D. Ye*3, N. Y. Kim4, E. J. Youn3, J. Y. Park3, E. Kang3, S. W. Hwang1, S. H. Park3, D.-H. Yang1, K.-J. Kim3, J.-S. Byeon1, S.-J. Myung1, S.-K. Yang3

1University of Ulsan College of Medicine, Asan Medical Centre, Gastroenterology, Seoul, South Korea, 2University of Ulsan College of Medicine, Asan Medical Centre, Health Screening and Promotion Centre, Seoul, South Korea, 3University of Ulsan College of Medicine, Asan Medical Centre, Gastroenterology, Inflammatory Bowel Disease Centre, Seoul, South Korea, 4University of Ulsan College of Medicine, Asan Medical Centre, Clinical Epidemiology and Biostatistics, Seoul, South Korea

P454: Combo-therapy in infliximab-resistant inflammatory bowel disease patients: data from a tertiary referral centreECCO '16 Amsterdam
Year: 2016
Authors:

S. Renna*, G. Rizzuto, E. Orlando, M. Affronti, M. Cottone, A. Orlando

‘Villa Sofia-Cervello’ Hospital, Division of Internal Medicine, Palermo, Italy

P455: The effect of concurrent HIV-1 infection on the management of patients with inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

T. H. Ho, R. Fausel, J. Torres, J. J. Yang, T. H. Swartz, J. A. Aberg, J.-F. Colombel, S. Mehandru*

Icahn School of Medicine at Mount Sinai, New York, New York, United States

P456: Efficacy and safety of TNF antagonist for the treatment of internal fistulising Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

A. Huguet1, A.-L. Mallet1, V. Desfourneaux1, L. Siproudhis1, J.-F. Bretagne2, G. Bouguen*2

1Université Rennes 1 & CHU Pontchaillou Rennes, Service de chirurgie digestive, Rennes, France, 2Université Rennes 1 & CHU Pontchaillou Rennes, Service des Maladies de l’Appareil Digestif, Rennes, France

P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysisECCO '16 Amsterdam
Year: 2016
Authors:

K. Diederen*1, L. de Ridder2, P. van Rheenen3, V. Wolters4, L. Mearin5, G. Damen6, T. de Meij7, H. van Wering8, L. Tseng1, M. Oomen9, J. de Jong9, M. Benninga1, A. Kindermann1

1Academic Medical Centre, Department of Paediatric Gastroenterology and Nutrition, Amsterdam, Netherlands, 2Erasmus MC-Sophia Children’s Hospital, Department of Paediatric Gastroenterology, Rotterdam, Netherlands, 3University Medical Centre Groningen, Department of Paediatric Gastroenterology, Groningen, Netherlands, 4University Medical Centre Utrecht, Department of Paediatric Gastroenterology, Utrecht, Netherlands, 5Leids Universitair Medisch Centrum, Department of Paediatrics, Leiden, Netherlands, 6Radboud University Medical Centre, Department of Paediatric Gastroenterology, Nijmegen, Netherlands, 7VU University Medical Centre, Department of Paediatric Gastroenterology, Amsterdam, Netherlands, 8Amphia Hospital, Department of Paediatrics, Breda, Netherlands, 9Academic Medical Centre, Department of Paediatric Surgery, Amsterdam, Netherlands

P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD auditECCO '16 Amsterdam
Year: 2016
Authors:

A. St. Clair Jones*1, S. Murray2

1Brighton and Sussex University Hospitals NHS Trust, Pharmacy, Brighton, United Kingdom, 2Royal College of Physicians, Clinical Effectiveness and Evaluation Unit, London, United Kingdom

P459: Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remissionECCO '16 Amsterdam
Year: 2016
Authors:

M. Iborra*1, B. Navarro1, X. Cortes2, M. Boscá3, T. Blazquez1, J. Herreras1, G. Trejo3, B. Beltrán1, P. Nos1

1Hospital Universitari i Politecnic La Fe, Gastroenterology, Valencia, Spain, 2Hospital de Sagunto, Gastroenterology, Sagunto, Spain, 3Hospital Clínic Valencia, Gastroenterology, Valencia, Spain

P460: Effect of fertility treatment on inflammatory bowel disease outcomesECCO '16 Amsterdam
Year: 2016
Authors:

M. Bejaoui*, C. Landman, J. Kirchgesner, A. Bourrier, I. Nion-Larmurier, H. Sokol, L. Beaugerie, J. Cosnes, P. Seksik

Saint Antoine Hospital, Gastroenterology & Nutrition, Paris, France

P461: Clinical benefit of adalimumab after surgery in the treatment of complex perianal Crohn’s disease: a tertiary referral centre experienceECCO '16 Amsterdam
Year: 2016
Authors:

G. Solina*1, S. Renna2, E. Orlando2, M. Affronti2, M. Cottone2, A. Orlando2

1’Villa Sofia-V. Cervello’ Hospital, Division of Surgery, Palermo, Italy, 2’Villa Sofia-Cervello’ Hospital, Division of Internal Medicine, Palermo, Italy

P462: Adalimumab improves treatment satisfaction with medication and work productivity amongst patients with ulcerative colitis in a clinical practice setting: results from INSPIRADAECCO '16 Amsterdam
Year: 2016
Authors:

S. Travis*1, B. Feagan2, L. Peyrin-Biroulet3, R. Panaccione4, S. Danese5, A. Lazar6, A. Robinson7, J. Petersson7, M. Bereswill6, M. Skup7, N. Chen7, S. Wang7, R. Thakkar7, J. Chao7

1Oxford University Hospitals, Oxford, United Kingdom, 2Robarts Research Institute, Ontario, Canada, 3University Hospital of Nancy, Les Nancy, France, 4University of Calgary, Medicine, Calgary, Canada, 5Istituto Clinico Humanitas, Milan, Italy, 6AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany, 7AbbVie Inc, North Chicago, Illinois, United States

P463: Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

D. Ishikawa*, T. Osada, K. Haga, T. Kodani, T. Shibuya, S. Watanabe

Juntendo University, Department of Gastroenterology, Tokyo, Japan